People
After four months of looking, Five Prime Therapeutics has found its new CEO.
Allergan is a good example of how many mergers and acquisitions over a very short period of time created a large, international company.
So this year, Moderna has lost the head of its cancer division, its top lawyer, and its chief business officer.
Alex Azar worked at the Department of Health and Human Services under President George W. Bush before joining drugmaker Eli Lilly.
Cydan snagged $34M to fund its rare disease pipeline and also tapped two new members of its executive leadership team.
Ronald Evans believes he’s much closer to a fat-burning, muscle-growing drug that won’t, uh, give you cancer.
Kare Schultz will become Teva’s fourth CEO in a decade, and its second outsider.
PRESS RELEASES